PortfoliosLab logo

ANI Pharmaceuticals, Inc. (ANIP)

Equity · Currency in USD · Last updated Jun 25, 2022

Company Info

ISINUS00182C1036
CUSIP00182C103
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Trading Data

Previous Close$27.22
Year Range$23.09 - $56.85
EMA (50)$28.53
EMA (200)$32.84
Average Volume$109.04K
Market Capitalization$469.46M

ANIPShare Price Chart


Chart placeholderClick Calculate to get results

ANIPPerformance

The chart shows the growth of $10,000 invested in ANI Pharmaceuticals, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $5,181 for a total return of roughly -48.19%. All prices are adjusted for splits and dividends.


ANIP (ANI Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ANIPReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M0.70%-0.75%
YTD-37.26%-17.93%
6M-43.20%-17.23%
1Y-12.07%-7.78%
5Y-9.46%9.92%
10Y6.37%11.55%

ANIPMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ANIPSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ANI Pharmaceuticals, Inc. Sharpe ratio is -0.20. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


ANIP (ANI Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ANIPDividend History


ANI Pharmaceuticals, Inc. doesn't pay dividends

ANIPDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ANIP (ANI Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ANIPWorst Drawdowns

The table below shows the maximum drawdowns of the ANI Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ANI Pharmaceuticals, Inc. is 96.08%, recorded on Jun 25, 2013. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.08%Jul 13, 2011491Jun 25, 2013
-46.31%May 4, 201084Aug 31, 2010176May 12, 2011260
-20.13%Jun 1, 201114Jun 20, 201112Jul 7, 201126
-17.71%Jan 15, 201016Feb 8, 20108Feb 19, 201024
-12.56%Feb 22, 20103Feb 24, 201013Mar 15, 201016
-9.58%May 16, 20112May 17, 20113May 20, 20115
-7.45%Mar 16, 20105Mar 22, 20102Mar 24, 20107
-5.3%Mar 25, 20104Mar 30, 201013Apr 19, 201017
-3.43%Jan 12, 20102Jan 13, 20101Jan 14, 20103
-3.23%Apr 27, 20101Apr 27, 20102Apr 29, 20103

ANIPVolatility Chart

Current ANI Pharmaceuticals, Inc. volatility is 100.16%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ANIP (ANI Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Portfolios with ANI Pharmaceuticals, Inc.


Loading data...